Aztreonam, 544
in trauma patients, 529
Babesia microti, 352
Babesiosis, 352
Bacillus atrophaeus, 466
Bacitracin, 283
Bacteremia, 113
burn wound infections and, 368
Bacterial endocarditis, 27, 69
Bacterial meningitis, 153
Bacterial pathogens, 14
Bacteriuria, 288
Bacteroides, 352
Bacteroides fragilis, 130, 343
Band keratopathy, 72
Band ligation, 345
Barium enema (BE), 85
Bartonella, 352, 380
Basilar diastolic blowing murmur, physical
findings
diagnostic features, 58
noninfectious mimics, 58
PE findings, 58
B-cell depletion, 379.See alsoBiologic agents
B-cell lymphoma, 89
Behc ̧et’s disease, 137, 378
BH4.SeeTetrahydrobiopterin (BH4)
Binax Now^1 Malaria Test, 324, 325
Biologic agents, 377, 379
adverse event reporting, 384
anti-interleukin (IL)-1/6/12/23, 378
anti-Janus kinase 3 (JAK3), 378
anti TNF-a, 378
bacterium, 380
B-cell depletion and, 379
immune dysregulation diseases, mimics of
sepsis in, 384
mycobacterium, 380
mycoses, 380–382
parasites, 380–382
in surgical considerations, 383–384
T-cell activation and migration and, 379–380
therapeutic targets, 378–380
viruses, 382–383
Biological warfare
history of, 435–437
Bioterrorism
agents, classifications of, 434
assessing patient for category A agents, 443–453
assessing patient for category B agents, 454–459
assessing patient for category C agents, 454–459
decontamination of patient, 466
defined, 432–433
diagnosis for, 466, 467–468
epidemiologic characteristics of, 438
history of biological warfare, 435–437
index of suspicion, 433
infection control, 466
[Bioterrorism]
protect yourself, 433
psychological consequences, 473
radiographic findings, chest, 460–465
syndromic-based isolation precautions, 439
transmission-based isolation precautions, 440–442
treatment for adult, 469–472
Biotransformation of drugs, 523
Bites, skin and soft tissue infections and, 301–302
Blood cultures, 208
endocarditis (SBE/ABE) and, 232–234
Blood product transfusion, 7–8
Bloodstream infections (BSI), 220, 223, 225, 226, 268.
See alsoCatheter-related bloodstream
infections (CRBSI)
in SOT recipients, 403–404
Blood urea nitrogen (BUN), 26
Blunt chest trauma, 524
B-lymphocyte/humoral immunity (HI), CAP and,
167–169
B1/NAP1 strain, ofC. difficile, 271–272
microbiology of, 275
BOOP.SeeBronchiolitis obliterans organizing
pneumonia (BOOP)
Borrelia burgdorferi, 29, 157
Brachial plexopathy, physical findings
diagnostic features, 63
noninfectious mimics, 63
Brain
abscess
clinical and radiologic diagnosis of, 85–86
mimic of, 88–89
bacterial infections
listeria, 158
lyme disease, 157–158
mycoplasma pneumonia, 159
neurosyphilis, 158
spirochetal, 157
TB, 155–157
meningitis and, 135
tumor, 88–89
vein infections
cytomegalovirus (CMV), 159–160
herpes simplex (HSV-1), 59
rabies, 160–161
West Nile virus (WNV), 160
Branch retinal artery occlusion, 69
Branch retinal vein occlusion, 70
Bronchiolitis obliterans organizing pneumonia
(BOOP), 1, 170, 174, 515
Bronchoalveolar lavage (BAL), 188, 189, 424
Bronchopneumonia, 92
Brucella, 380
BSI.SeeBloodstream infections (BSI)
B/T-lymphocyte function (HI/CMI), CAP and, 169
Bubonic plague, 477
Budd-Chiari syndrome, 266
Bullous impetigo, 34
BUN.SeeBlood urea nitrogen (BUN)
Burkholderia cepacia, 392
Index 559